These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16569995)

  • 1. Management of the patient receiving parenteral biologic therapy.
    Vizcarra C; Belcher D
    J Infus Nurs; 2006; 29(2):63-71. PubMed ID: 16569995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparing dermatology nurses: biologic therapy for psoriasis.
    Young MS
    Dermatol Nurs; 2003 Oct; 15(5):413-6, 419-23; quiz 424. PubMed ID: 14619318
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab for rheumatoid arthritis. Practical guidance for optimizing treatment.
    Furfaro N
    Adv Nurse Pract; 2008 Jan; 16(1):61-4. PubMed ID: 20014746
    [No Abstract]   [Full Text] [Related]  

  • 4. Best practices in the management of toxicities related to anti-EGFR agents for metastatic colorectal cancer.
    Ouwerkerk J; Boers-Doets C
    Eur J Oncol Nurs; 2010 Sep; 14(4):337-49. PubMed ID: 20580896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse events in bevacizumab and chemotherapy: patient management.
    Blowers E; Hall K
    Br J Nurs; 2009 Apr 9-22; 18(7):424-8. PubMed ID: 19373187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the clinical nurse specialist in the assessment and management of biologic therapies.
    Oliver SM
    Musculoskeletal Care; 2011 Mar; 9(1):54-62. PubMed ID: 20939102
    [No Abstract]   [Full Text] [Related]  

  • 7. Infusion reactions triggered by monoclonal antibodies treating solid tumors.
    Carney PH; Ollom CL
    J Infus Nurs; 2008; 31(2):74-83. PubMed ID: 18344767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What kind of rash is it?: deciphering the dermatologic toxicities of biologic and targeted therapies.
    Esper P; Gale D; Muehlbauer P
    Clin J Oncol Nurs; 2007 Oct; 11(5):659-66. PubMed ID: 17962174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. You can make a difference in the administration of intravenous immunoglobulin therapy.
    Duff K
    J Infus Nurs; 2006; 29(3 Suppl):S5-14. PubMed ID: 16878850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing drug infusion reactions: focus on cetuximab monoclonal antibody therapy.
    Wilkes G
    Clin J Oncol Nurs; 2008 Jun; 12(3):530-2. PubMed ID: 18515254
    [No Abstract]   [Full Text] [Related]  

  • 11. Biological nurse specialist: goodwill to good practice.
    Palmer D; El Miedany Y
    Br J Nurs; 2010 Apr 22-May 13; 19(8):477-80. PubMed ID: 20505612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical breakthroughs in EGFR inhibition: applying the science to your clinical practice.
    Morse L
    ONS News; 2006; 21(8 Suppl):59-60. PubMed ID: 16925155
    [No Abstract]   [Full Text] [Related]  

  • 13. Infusion-related risks associated with chemotherapy.
    Gallimore E
    Nurs Stand; 2016 Feb; 30(25):51-60. PubMed ID: 26884041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic Therapies for Autoimmune and Connective Tissue Diseases.
    Wolfe RM; Ang DC
    Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive nursing approach to infliximab infusion therapy.
    Stone WJ
    J Infus Nurs; 2003; 26(6):380-7. PubMed ID: 14624179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nurse's role in administration of intravenous immunoglobulin therapy.
    Kirmse J
    Home Healthc Nurse; 2009 Feb; 27(2):104-11; quiz 112-3. PubMed ID: 19212223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced nausea and vomiting (CINV): prevention, detection, and treatment--how are we doing?
    ONS News; 2004; 19(9 Suppl):61-2. PubMed ID: 15478591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setting up and priming an intravenous infusion.
    Younger G; Khan M
    Nurs Stand; 2008 Jun 11-17; 22(40):40-4. PubMed ID: 18610932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraperitoneal chemotherapy: implications beyond ovarian cancer.
    Marin K; Oleszewski K; Muehlbauer P
    Clin J Oncol Nurs; 2007 Dec; 11(6):881-9. PubMed ID: 18063547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of i.v. chemotherapy & biotherapy agents.
    Ohio Nurses Association
    Ohio Nurses Rev; 2008; 83(1):6-7. PubMed ID: 18410049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.